Drug Shortage Report for BIO-GABAPENTIN

Last updated on 2019-05-17 History
Report ID 47948
Drug Identification Number 02450186
Brand name BIO-GABAPENTIN
Common or Proper name GABAPENTIN
Company Name BIOMED PHARMA
Market Status CANCELLED POST MARKET
Active Ingredient(s) GABAPENTIN
Strength(s) 600MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code N03AX
ATC description ANTIEPILEPTICS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2018-05-01
Estimated end date
Actual end date 2019-05-16
Shortage status Resolved
Updated date 2019-05-17
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 9450 BOUL. LANGELIER
MONTREAL, QUEBEC
CANADA H1P 3H8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v15 2019-05-17 English Compare
v14 2019-05-16 French Compare
v13 2019-05-16 English Compare
v12 2018-12-05 French Compare
v11 2018-12-05 English Compare
v10 2018-11-26 French Compare
v9 2018-11-26 English Compare
v8 2018-11-09 French Compare
v7 2018-11-09 English Compare
v6 2018-10-19 French Compare
v5 2018-10-19 English Compare
v4 2018-09-18 French Compare
v3 2018-09-18 English Compare
v2 2018-05-02 French Compare
v1 2018-05-02 English Compare

Showing 1 to 15 of 15